PedAM
Pediatric Disease Annotations & Medicines
| Disease | pertussis |
| Phenotype | C0039614|tetanus |
| Sentences | 12 |
| PubMedID- 22892100 | In china, use of whole cell pertussis vaccine combined with diphtheria and tetanus toxoids (dtwp) was started in 1980s. |
| PubMedID- 23703506 | In 2009, recommendations were published to combine the next tetanus immunisation with a pertussis immunisation; therefore pertussis vaccination coverage might improve in the coming years. |
| PubMedID- 26156158 | As shown in table 6, the vaccination coverage observed in this survey was higher than that reported for the whole cameroon by who [28], and by the 2011 cameroonian dhs for the whole country and the west region [4].table 6vaccines coverage (by card plus parents’ recall) compared to latest data for cameroon from who and demographic health survey (dhs)vaccinepresent study (n = 502)who (2013) [26]dhs (2011) [4]cameroon (n=2265)west region, cameroon (n=272)bcg99.88287.195.9dtwphibhepb – 198.89585.594.4dtwphibhepb – 298.28978.387dtwphibhepb – 394.88968.475.5opv – 097.6n.a71.784.4opv – 198.4n.a93.392.5opv – 297.8n.a85.587.5opv – 3958869.876.6measles91.28370.679.8yellow fever91.28369.377.7not vaccinated0n.a.4.52.3partially vaccinated14.1n.a.49.840.7fully vaccinated85.9n.a.50.259.3fully vaccinated ≤12 months a73.4n.a.45.1n.a.bcg bacille calmette guérin, opv oral polio vaccine, dtwphibhepb diphtheria and tetanus toxoid with whole cell pertussis, haemophilus influenzae type b and hepatitis b vaccines, n.a. |
| PubMedID- 24004825 | The availability of low antigen-content acellular pertussis vaccines (combined with diphtheria and tetanus) allows for regular boosting against pertussis throughout life. |
| PubMedID- 23330226 | Immunization against pertussis (combined with those against tetanus and diphtheria) has been included in the who’s expanded programme on immunization (epi) in 1974. accordingly to data provided for 2008, the estimated worldwide rate of newborns immunized with three doses was about 82%. |
| PubMedID- 24621240 | Aim: to evaluate diphtheria and tetanus toxoids combined with acellular pertussis (dtap) and diphtheria and tetanus toxoids combined with whole-cell pertussis (dtwp) with regard to local, systemic and febrile reactions. |
| PubMedID- 24476570 | The infant formulation of the pertussis vaccine, with tetanus and diphtheria +/- inactivated polio +/- haemophilus influenza b vaccine, contains higher concentrations of b. pertussis antigens and is used in children from 2 months until 7 years of age. |
| PubMedID- 23835871 | Bcg bacillus calmette guérin, ipv inactivated polio vaccine, dpt diphtheria and tetanus toxoids combined with pertussis vaccine, dt diphtheria and tetanus toxoids, mr measles and rubella-combined vaccine, jev japanese encephalitis vaccine, hib haemophilus influenzae type b vaccine, pcv7 7-valent str. |
| PubMedID- 21999521 | Methods: we present national immunization coverage estimates for the third dose of diphtheria and tetanus toxoid with pertussis (dtp3) vaccine and the first dose of measles containing vaccine (mcv) during 2000, 2005 and 2010 and report the average annual relative percent change during 2000-2005 and 2005-2010. |
| PubMedID- 21604922 | Therefore, to better protect infants through the herd effect, a programme of booster pertussis vaccination with decennial tetanus toxoid, has been implemented in adults. |
| PubMedID- 24589970 | Dpt, diphtheria, tetanus toxoids, combined with acellular pertussis vaccine; hib, hemophilus influenzae type b t-conjugated vaccine; pcv7, 7-valent pneumococcal conjugated vaccine; rota, rotavirus vaccine; bcg, bacillus calmette-guérin; mr, measles and rubella combined vaccine; ipv, inactivated polio vaccine. |
| PubMedID- 20562056 | The first childhood vaccination, at age 3 months, includes immunization against diphtheria and tetanus, along with pertussis, polio, and haemophilus influenzae type b. repeat inoculations are given at ages 5 and 12 months, and a booster vaccination against diphtheria and tetanus is given at age 5 years. |
Page: 1